Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Gilardi

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Japanese Journal of Radiology|June 25, 2020
<sup>18</sup>F-FDG PET/CT in asymptomatic patients with COVID-19: the submerged iceberg surfacesMarzia Colandrea, Laura Gilardi, Laura L Travaini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2010
Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapyLaura Gilardi, Concetta De Cicco, Marco Colleoni, et al.
Anti-Cancer Drugs|March 8, 2006
Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicityDaris Ferrari, Claudia Carbone, Carla Codecà, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2013
Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumoursStefano Severi, Oriana Nanni, Lisa Bodei, et al.
Future Oncology (London, England)|December 9, 2021
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?Francesca Magnoni, Giovanni Corso, Laura Gilardi, et al.
Ecancermedicalscience|April 26, 2016
PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerLaura L Travaini, Maria G Zampino, Marzia Colandrea, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2015
Long-term results of PRRT in advanced bronchopulmonary carcinoidAnnapaola Mariniello, Lisa Bodei, Carmine Tinelli, et al.
Oncology|June 10, 2020
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?Giovanni Corso, Laura Gilardi, Antonia Girardi, et al.
Breast (Edinburgh, Scotland)|June 19, 2012
Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?Concetta De Cicco, Laura Gilardi, Edoardo Botteri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Interim <sup>18</sup>F-FDG PET/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic ReviewCristina Garibaldi, Sara Ronchi, Marta Cremonesi, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Japanese Journal of Radiology|June 25, 2020
<sup>18</sup>F-FDG PET/CT in asymptomatic patients with COVID-19: the submerged iceberg surfacesMarzia Colandrea, Laura Gilardi, Laura L Travaini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2010
Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapyLaura Gilardi, Concetta De Cicco, Marco Colleoni, et al.
Anti-Cancer Drugs|March 8, 2006
Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicityDaris Ferrari, Claudia Carbone, Carla Codecà, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2013
Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumoursStefano Severi, Oriana Nanni, Lisa Bodei, et al.
Future Oncology (London, England)|December 9, 2021
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?Francesca Magnoni, Giovanni Corso, Laura Gilardi, et al.
Ecancermedicalscience|April 26, 2016
PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerLaura L Travaini, Maria G Zampino, Marzia Colandrea, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2015
Long-term results of PRRT in advanced bronchopulmonary carcinoidAnnapaola Mariniello, Lisa Bodei, Carmine Tinelli, et al.
Oncology|June 10, 2020
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?Giovanni Corso, Laura Gilardi, Antonia Girardi, et al.
Breast (Edinburgh, Scotland)|June 19, 2012
Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?Concetta De Cicco, Laura Gilardi, Edoardo Botteri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Interim <sup>18</sup>F-FDG PET/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic ReviewCristina Garibaldi, Sara Ronchi, Marta Cremonesi, et al.
Pageof 3